CA50109-1 - 0x00000000000072FF
Males & Females of Non-Childbearing Potential
Card
* Stipend may pay up to reflected amount.
Start Date:
November 16, 2026 - 10:30am
End Date:
January 22, 2027 - 9:30am
Study Details
Study Number: CA50109
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $19,500.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat autoimmune diseases and advanced cancer.
Route of Administration: Oral
Blood Draws: 73
Study Schedule
Schedule Type: Long Term
Study Length: One - 5 Night Stay, One - 9 Night Stay, One - 18 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 11/3/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 11/3/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 11/16/2026 10:30:00 AM | Saturday | 11/21/2026 6:45:00 AM | 1 | Phoenix |
| Check-In | Monday | 11/30/2026 10:30:00 AM | Wednesday | 12/9/2026 6:45:00 AM | 2 | Phoenix |
| Check-In | Tuesday | 12/22/2026 10:30:00 AM | Saturday | 1/9/2027 6:45:00 AM | 3 | Phoenix |
| Phone participant | Friday | 1/22/2027 9:30:00 AM | 3 | Phoenix |
